Rehabilitation Mobility Exoskeleton
Developed by Taixi Intelligent, the Rehabilitation Mobility Exoskeleton combines powered lower limb assistance with wheelchair integration, targeting patients who require support for standing and walking rehabilitation. The system represents Taixi’s entry into medical rehabilitation applications, building on the company’s expertise in bipedal robot technology.
Product Overview
The Rehabilitation Mobility Exoskeleton (also referred to as the wheelchair-integrated exoskeleton) functions as a dual-purpose device combining mobility wheelchair features with powered exoskeleton walking support. Unlike standalone exoskeleton systems, this integrated approach provides users with baseline mobility while enabling progressive rehabilitation training.
The design philosophy centers on making exoskeleton technology accessible for patients who may not have sufficient upper body strength or balance capabilities to operate traditional exoskeleton systems from a standing start.
Key Features
At a target volume price under 15,000 RMB, the Rehabilitation Mobility Exoskeleton pairs wheelchair mobility with AI-powered lower limb assistance for progressive passive-to-active gait training.
- Wheelchair Integration: Combined mobility platform eliminates the need for separate devices for daily transport and rehabilitation training
- Progressive Training Modes: Supports passive walking assistance through active participation modes as patient capability improves
- Compact Form Factor: Designed for use in hospital rehabilitation departments and home environments
- Bipedal Technology Foundation: Built on Taixi’s core competency in bipedal robot mechanics and dynamic balance research
Technical Specifications
At 3–7 hours of battery operation per session, the Taixi exoskeleton delivers AI-controlled walking assistance across passive and active rehabilitation modes for lower limb dysfunction patients.
| Parameter | Specification |
|---|---|
| Weight | Not disclosed |
| Battery Life | 3-7 hours (varies by use mode) |
| Intended Users | Lower limb dysfunction patients |
| Control Method | AI-powered movement sensing |
| Price Target | Sub-15,000 RMB at volume production |
Note: Technical specifications are based on publicly available information and company statements. Final product specifications may vary.
Clinical Applications
The rehabilitation mobility exoskeleton targets patients with:
- Lower limb paralysis requiring walking training
- Stroke survivors in rehabilitation programs
- Spinal cord injury patients with partial motor function
- Elderly patients with mobility decline
- Post-surgical orthopedic rehabilitation cases
The system is designed for use under supervision of rehabilitation therapists in clinical settings, with potential for home-based continuation of training programs.
Regulatory Status
| Region | Status | Notes |
|---|---|---|
| China (NMPA) | Pending | Pursuing Class II medical device certification |
| Europe (CE) | Not Applied | - |
| United States (FDA) | Not Applied | - |
Taixi is actively pursuing Class II medical device production licensing in China. Part of the company’s 2024 angel round funding was designated for certification processes and facility construction to meet regulatory requirements.
Development Background
Taixi’s rehabilitation exoskeleton development draws from founder Liang Linchao’s research in bipedal humanoid robots at Chemnitz University of Technology in Germany. The technical approach emphasizes dynamic balance capability, with the long-term vision of creating exoskeletons that can maintain stability independently, potentially allowing users with no leg function to walk.
The company positions the rehabilitation product as a step toward more ambitious “mecha” exoskeleton systems that would combine powered walking with full body support.
Frequently Asked Questions
When will the Taixi rehabilitation exoskeleton receive NMPA approval?
As of early 2026, Taixi is in the process of applying for Class II medical device certification. The company has not announced a specific timeline for expected approval.
How does the Taixi exoskeleton differ from other rehabilitation robots?
The Taixi system integrates wheelchair functionality with powered exoskeleton training, providing a dual-purpose device. This approach targets users who may need baseline mobility support while undergoing rehabilitation training.
What is the expected price of the Taixi rehabilitation exoskeleton?
According to company statements, the target price at volume production could be under 15,000 RMB for the basic configuration, representing approximately 50% reduction compared to some existing market alternatives.
Browse related categories
Sources
Publicly available references used for the data on this page. See data methodology for verification standards.